Regulatory oversight crucial as mobile health apps reshape healthcare
These apps could significantly contribute to the efficiency and accessibility of healthcare services.
Regulatory oversight will be crucial in ensuring the safety, and effectiveness of mobile health (mHealth) apps, GlobalData reported.
“One of the key advantages of regulated mHealth apps is their ability to improve access to healthcare services, especially in underserved or remote areas. mHealth apps enable patients to monitor their health, access medical information, consult healthcare professionals remotely, and even receive timely reminders for medication and appointments,” Alexandra Murdoch, Senior Medical Analyst at GlobalData, said.
“This not only reduces the burden on traditional healthcare facilities but also empowers patients to actively participate in their healthcare journey.”
In a report, GlobalData noted that the regulated mHealth app market value is expected to reach $15.6b in 2033.
The market’s growth was particularly boosted by the pandemic, and was sustained after the end of the COVID-19 pandemic.
“As the demand for digital healthcare solutions continues to rise, the importance of regulatory oversight cannot be overstated,” she added.
“Regulated mHealth apps undergo continuous monitoring, updates, and evaluations to ensure ongoing compliance with evolving standards and best practices.
